| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 26, 2022 | 'Beginning of a broader loss': Pharma execs call regulators and legislators to action four months post-Roe | Two decades after the FDA first approved fulvestrant to treat a type of breast cancer, AstraZeneca says it has garnered data that could usher in a new era of treatment.
Two drugs are coming under the spotlight today. In separate trials invo... |
| Oct 26, 2022 | FDA explains why it won't pull Jazz's accelerated approval despite a failed confirmatory trial | When does a failed confirmatory trial evaluating overall survival not amount to a request from FDA to pull an accelerated approval for a cancer drug? That’s the situation right now for Jazz Pharmaceuticals’ second-l... |
| Oct 26, 2022 | Glyn Edwards takes chairman role at UK oncolytic virus startup emerging out of stealth | Oncolytic viruses — viruses that can selectively replicate in cancer cells and kill them — have been steadily attracting investment and curiosity. However, for the most part, those candidates have not quite panned out t... |
| Oct 26, 2022 | As Revlimid faces more competition, Bristol Myers' goal is to 'grow the company' | Bristol Myers Squibb’s Q3 numbers were down on the latest quarter, but the Big Pharma is looking to stay the course, maintaining overall 2022 revenue guidance in light of generics eating away at the profits of megablockbuste... |
| Oct 26, 2022 | Indian site for Jubilant Generics lands Form 483 for QC issues | Generics giant Jubilant has one of its manufacturing sites under the FDA’s microscope.
A 14-page inspection report from late July and early August of this year revealed six major observations at the Jubilant manufa... |
| Oct 26, 2022 | Viatris and others become latest targets of Novartis' Entresto patent litigation | Novartis protects its blockbusters like a bear and her cubs, recently taking a Gilenya patent battle all the way to the Supreme Court. Now it’s filing yet another federal court complaint in an attempt to drive off Entresto ... |
| Jun 13, 2021 | Botswana's Economic Recovery Efforts Gets $250 Million Boost | WASHINGTON, June 11, 2020 - Botswana's efforts to accelerate key economic reforms got a boost following the approval of a $250 million loan by the World Bank today. The Programmatic Economic Resilience and Green Recovery Development Policy ... |
| May 20, 2021 | TESLA, INC.
Recovery rally takes bitcoin back above $40k; Treasury proposal weighs on gains | The comments from U.S. officials come one day after a brutal sell-off on concerns over tighter regulation in China and unease over the extent of leveraged positions among investors sank the world's biggest cryptocurrency to its lowest level... |
| Mar 31, 2021 | 6 treatments that COVID patients receive to survive: From antibodies to remdesivir | March 31, 2021 8 min read
This article was translated from our Spanish edition using AI technologies. Errors may exist due to this process. This story originally appeared on The Conversation
By William G. Bain , University of Pittsburgh ; G... |
| Mar 2, 2021 | Using a collective ‘virtuous cycle’ to break the pandemic | Medical schools teach students a four-part “virtuous cycle” in which one step positively reinforces the next: Assess the patient. Implement a therapeutic plan. Assess the patient’s response. Revise the therapeutic plan as needed.
In an emer... |
| Feb 18, 2021 | Here’s why a surprising number of healthcare workers are rejecting COVID-19 vaccines despite having witnessed the immense suffering of the pandemic | A nurse administering a dose of the Moderna vaccine in Los Angeles. Twenty to 40% of frontline workers in Los Angeles have refused a shot. Mario Tama/Getty Images
COVID-19 vaccine hesitancy is above average for healthcare workers.
Insider s... |
| Feb 17, 2021 | Here’s why a surprising number of healthcare workers are rejecting the vaccine, despite having witnessed the immense suffering of the COVID-19 pandemic | A nurse administers a dose of the Moderna vaccine in Los Angeles, California. Between 20 and 40% of frontline workers in Los Angeles have refused a shot. Mario Tama/Getty Images
Vaccine hesitancy is above average for healthcare workers work... |
| Feb 12, 2021 | Covid-19 roundup: Fauci says first graders could have access to vaccine by September — report; EMA begins rolling review of CureVac vaccine | NIAID director Anthony Fauci says kids as young as first grade could be eligible for Covid-19 vaccines by the time school starts in September, per Propublica.
Fauci told Propublica that age de-escalation trials are un... |
| Feb 11, 2021 | Study: Arthritis drug reduces COVID mortality for severely ill | Sign up for our daily briefingMake your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Enter your email address
Please enter a valid email.
Please enter a valid email.
Subscription failedSub... |
| Jan 23, 2021 | A gout drug shows promise for Covid-19, but skeptics worry about trusting science by press release | A press release from a Canadian research group raised hopes that treating people recently diagnosed with Covid-19 with colchicine, a drug commonly used to treat gout, could reduce the risk they will need to be hospitalized.
But outside expe... |
| Dec 15, 2020 | The most dangerous health myths debunked in 2020, from herd immunity to COVID-19 ‘hygiene theatre’ | Volunteers disinfecting a theatre in Wuhan, China. Aly Song/ REUTERS
2020, a year dominated by a global pandemic, was rife with dangerous health misinformation.
False and misleading claims suggested that wearing a mask was dangerous, that o... |
| Nov 6, 2020 | Covid-19 roundup: Novartis treatment comes up short in PhIII; Humanigen expands trial, but draws criticism | A major player trying to adapt an anti-inflammatory for Covid-19 has seen the drug fall flat.
Novartis reported Friday that a Phase III trial evaluating canakinumab in hospitalized Covid-19 cases with pneumonia and c... |
| Oct 22, 2020 | The US's third coronavirus surge may become the deadliest yet, experts say | An illustration of the novel coronavirus.
Getty Images
Daily coronavirus cases in the US have risen nearly 40%, on average, since the start of October.
Experts worry these cases will lead to the nation's deadliest surge of infections yet, a... |
| Oct 22, 2020 | It’s Time To Use Covid-19 Innovations And Systems To Reimagine TB Care | Mobile testing for Covid-19 in South Africa. Photographer: Waldo Swiegers/Bloomberg© 2020 Bloomberg Finance LP |
| Oct 20, 2020 | Massive Covid-19 Drug Trial Underscores Importance Of Controlled Clinical Studies | A photo taken in the late hours of August 17, 2020 shows a sign of the World Health Organization ... [+] (WHO) at their headquarters in Geneva amid the COVID-19 outbreak, caused by the novel coronavirus. (Photo by Fabrice COFFRINI / AFP) (P... |
| Sep 30, 2020 | Twelve things we know about Covid-19, thanks to health data research | Twelve things we know about Covid-19, thanks to health data research
30-09-2020
‘Twelve things we know about Covid-19, so far’, published by Health Data Research UK (HDRUK) demonstrates the absolute necessity for timely, secure access to he... |
| Aug 20, 2020 | The world desperately needs coronavirus treatments, even if we get a vaccine | Yuqing Liu/Business Insider
Hundreds of potential Covid-19 treatments have entered clinical testing in the last several months.
Some of those therapies are best suited to help during a certain stage of infection, while others target the bod... |
| Jul 23, 2020 | Using a global network of adaptive clinical trials to fight Covid-19 | Viruses like SARS-CoV-2 can circle the globe with astonishing speed by taking advantage of human networks. The global medical research community couldn’t immediately contain it because it had no comparable network for defense — but we are m... |
| Jul 8, 2020 | A flawed Covid-19 study gets the White House’s attention — and the FDA may pay the price | Studies in thousands of people on multiple continents now show the malaria drug hydroxychloroquine does not help patients hospitalized with Covid-19 live longer. But on Tuesday the White House, based on a new study that outsiders greeted wi... |
| Jul 1, 2020 | Preliminary trial results find antiviral drug lopinavir/ritonavir does not reduce death in hospitalised patients with COVID-19 | Preliminary trial results find antiviral drug lopinavir/ritonavir does not reduce death in hospitalised patients with COVID-19
01-07-2020
The ‘RECOVERY’ trial has released preliminary results showing lopinavir/ritonavir, an antiviral drug c... |
| Jul 1, 2020 | Карта стран с риском тяжёлой формы. Новости про ковид | Darina Obukhova Коронавирус 1 июля 2020, 15:39 Карта стран с риском тяжёлой формы. Новости про ковид
Главные новости за неделю про борьбу с пандемией.
Оставить комментарий... |
| Jun 18, 2020 | COVID-19 Report 7: Life-Saving Drug is Good News but no Time to Pop Champagne | wp_booster error:
td_api_base::get_key : a component with the ID: single_template_2 Key: show_featured_image_on_all_pages is not set.
/home/r8qkakm4wchc/public_html/wp-content/plugins/td-composer/legacy/common/wp_booster/td_api.php (rara-er... |
| Jun 18, 2020 | COVID-19 Report 7: Life-Saving Drug is Good News but no Time to Pop Champagne | wp_booster error:
td_api_base::get_key : a component with the ID: single_template_2 Key: show_featured_image_on_all_pages is not set.
/home/r8qkakm4wchc/public_html/wp-content/plugins/td-composer/legacy/common/wp_booster/td_api.php (rara-er... |
| Jun 18, 2020 | COVID-19 Report 7: Life-Saving Drug is Good News but no Time to Pop Champagne | wp_booster error:
td_api_base::get_key : a component with the ID: single_template_2 Key: show_featured_image_on_all_pages is not set.
/var/web/site/public_html/wp-content/plugins/td-composer/legacy/common/wp_booster/td_api.php (rara-error) ... |
| Jun 17, 2020 | Preliminary trial results find dexamethasone reduces death in hospitalised patients with severe respiratory complications of COVID-19 | Preliminary trial results find dexamethasone reduces death in hospitalised patients with severe respiratory complications of COVID-19
17-06-2020
The ‘RECOVERY’ trial has released preliminary results showing low-cost dexamethasone reduces de... |
| Jun 16, 2020 | Major study finds common steroid reduces deaths among patients with severe Covid-19 | A cheap, readily available steroid drug reduced deaths by a third in patients hospitalized with Covid-19 in a large study, the first time a therapy has been shown to possibly improve the odds of survival with the condition in the sickest pa... |
| Jun 9, 2020 | Preliminary results from RECOVERY trial on the use of hydroxychloroquine in hospitalised patients with COVID-19 | Preliminary results from RECOVERY trial on the use of hydroxychloroquine in hospitalised patients with COVID-19
09-06-2020
The ‘RECOVERY’ trial has released preliminary results showing no effect on mortality from the use of hydroxychloroqui... |
| Jun 5, 2020 | Study: Hydroxychloroquine had no benefit for hospitalized Covid-19 patients, possibly closing door to use of drug | A major clinical trial showed the malaria drug hydroxychloroquine had no benefit for patients hospitalized with Covid-19, likely closing the door to the use of the highly publicized medicine in the sickest patients — a use for which it was ... |
| May 1, 2020 | How the UK life sciences industry is rising to the challenge of Covid-19 by Kate Bingham | Crisis is the mother of invention and Covid-19 is no exception. But amid all the gloom are signs of a nascent revolution in how we create and develop new drugs, vaccines and diagnostics. The UK life sciences industry is rising to the challe... |
| Roche arthritis drug reduces death in hospitalized patients with severe Covid, Oxford researchers say | A drug used to treat people with rheumatoid arthritis appears to reduce the risk of death in hospitalized patients with severe Covid-19, especially when it was combined with the steroid dexamethasone.
Tocilizumab, an intravenous drug manufa... |